Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 11.9% on Analyst Upgrade
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded up 11.9% during trading on Tuesday after Canaccord Genuity Group raised their price target on the stock from $81.00 to $92.00. Canaccord Genuity Group currently has a buy rating on the stock. Rhythm Pharmaceuticals traded as high as $59.11 and last traded at $61.48. […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded up 11.9% during trading on Tuesday after Canaccord Genuity Group raised their price target on the stock from $81.00 to $92.00. Canaccord Genuity Group currently has a buy rating on the stock. Rhythm Pharmaceuticals traded as high as $59.11 and last traded at $61.48. […]
